Matt Davies
1PUBLICATIONS
5CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (1)
Sort by Publication Date:
|Feb 16, 2024
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial.Andreas H Diacon, Clifton E Barry, Alex Carlton
Pageof 1
